Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 1869.4
(9.08%)
INR 1869.4
(9.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 16.76 Billion INR | 0.0% |
| 2022 | 14.66 Billion INR | 16.13% |
| 2021 | 12.63 Billion INR | 20.49% |
| 2020 | 10.48 Billion INR | 21.44% |
| 2019 | 8.63 Billion INR | 33.07% |
| 2018 | 6.48 Billion INR | 20.16% |
| 2017 | 5.39 Billion INR | 34.41% |
| 2016 | 4.01 Billion INR | 30.22% |
| 2015 | 3.08 Billion INR | 22.51% |
| 2014 | 2.51 Billion INR | 45.46% |
| 2013 | 1.73 Billion INR | 36.26% |
| 2012 | 1.27 Billion INR | 18.48% |
| 2011 | 1.07 Billion INR | 37.6% |
| 2010 | 779.21 Million INR | 28.36% |
| 2009 | 607.07 Million INR | 2.69% |
| 2008 | 591.18 Million INR | -4.48% |
| 2007 | 618.92 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.58 Billion INR | 17.9% |
| 2023 Q2 | 4.1 Billion INR | 3.73% |
| 2023 Q3 | 4.35 Billion INR | 6.2% |
| 2023 Q4 | 3.89 Billion INR | -10.61% |
| 2023 Q1 | 3.95 Billion INR | 1.55% |
| 2023 FY | 14.66 Billion INR | 0.0% |
| 2022 Q2 | 3.59 Billion INR | 3.67% |
| 2022 Q4 | 3.89 Billion INR | 4.63% |
| 2022 FY | 14.66 Billion INR | 16.13% |
| 2022 Q1 | 3.46 Billion INR | 4.05% |
| 2022 Q3 | 3.72 Billion INR | 3.63% |
| 2021 Q1 | 3 Billion INR | 13.08% |
| 2021 Q2 | 3.03 Billion INR | 1.03% |
| 2021 Q3 | 3.26 Billion INR | 7.47% |
| 2021 Q4 | 3.32 Billion INR | 2.04% |
| 2021 FY | 12.63 Billion INR | 20.49% |
| 2020 Q1 | 2.4 Billion INR | 11.54% |
| 2020 Q2 | 2.68 Billion INR | 11.68% |
| 2020 Q4 | 2.65 Billion INR | -3.18% |
| 2020 Q3 | 2.74 Billion INR | 2.34% |
| 2020 FY | 10.48 Billion INR | 21.44% |
| 2019 Q4 | 2.15 Billion INR | -5.69% |
| 2019 Q1 | 1.92 Billion INR | 2.78% |
| 2019 Q2 | 2.27 Billion INR | 18.0% |
| 2019 FY | 8.63 Billion INR | 33.07% |
| 2019 Q3 | 2.28 Billion INR | 0.44% |
| 2018 Q1 | 1.46 Billion INR | 2.13% |
| 2018 Q3 | 1.59 Billion INR | 2.03% |
| 2018 Q4 | 1.87 Billion INR | 17.8% |
| 2018 FY | 6.48 Billion INR | 20.16% |
| 2018 Q2 | 1.55 Billion INR | 6.42% |
| 2017 Q3 | 1.41 Billion INR | 7.84% |
| 2017 Q1 | 1.23 Billion INR | 4.62% |
| 2017 FY | 5.39 Billion INR | 34.41% |
| 2017 Q4 | 1.43 Billion INR | 1.27% |
| 2017 Q2 | 1.31 Billion INR | 6.31% |
| 2016 Q1 | 850.79 Million INR | 3.87% |
| 2016 FY | 4.01 Billion INR | 30.22% |
| 2016 Q4 | 1.18 Billion INR | 14.85% |
| 2016 Q3 | 1.02 Billion INR | 7.38% |
| 2016 Q2 | 957.22 Million INR | 12.51% |
| 2015 Q1 | 701.27 Million INR | 10.23% |
| 2015 Q2 | 775.42 Million INR | 10.57% |
| 2015 Q4 | 819.09 Million INR | 3.33% |
| 2015 FY | 3.08 Billion INR | 22.51% |
| 2015 Q3 | 792.69 Million INR | 2.23% |
| 2014 Q2 | 571.4 Million INR | -1.19% |
| 2014 Q3 | 608.83 Million INR | 6.55% |
| 2014 FY | 2.51 Billion INR | 45.46% |
| 2014 Q1 | 578.28 Million INR | 50.89% |
| 2014 Q4 | 636.19 Million INR | 4.49% |
| 2013 Q2 | 409.31 Million INR | 4.62% |
| 2013 Q4 | 383.24 Million INR | -10.45% |
| 2013 FY | 1.73 Billion INR | 36.26% |
| 2013 Q1 | 391.24 Million INR | 35.53% |
| 2013 Q3 | 427.96 Million INR | 4.56% |
| 2012 Q2 | 271.45 Million INR | -17.66% |
| 2012 Q1 | 329.69 Million INR | 26.8% |
| 2012 Q4 | 288.67 Million INR | -9.48% |
| 2012 FY | 1.27 Billion INR | 18.48% |
| 2012 Q3 | 318.91 Million INR | 17.48% |
| 2011 Q2 | 214.74 Million INR | 0.0% |
| 2011 FY | 1.07 Billion INR | 37.6% |
| 2011 Q4 | 260.01 Million INR | -2.88% |
| 2011 Q3 | 267.71 Million INR | 24.67% |
| 2010 FY | 779.21 Million INR | 28.36% |
| 2009 FY | 607.07 Million INR | 2.69% |
| 2008 FY | 591.18 Million INR | -4.48% |
| 2007 FY | 618.92 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 72.566% |
| Hester Biosciences Limited | 3.04 Billion INR | -450.583% |
| Aarti Drugs Limited | 25.28 Billion INR | 33.687% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 7.641% |
| Albert David Limited | 3.62 Billion INR | -362.609% |
| Alembic Limited | 1.57 Billion INR | -964.722% |
| Alkem Laboratories Limited | 126.67 Billion INR | 86.763% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -999.775% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -254.186% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -4088.254% |
| Brooks Laboratories Limited | 794.86 Million INR | -2009.526% |
| Eris Lifesciences Limited | 20.09 Billion INR | 16.543% |
| FDC Limited | 19.42 Billion INR | 13.699% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 26.561% |
| Gufic Biosciences Limited | 8.06 Billion INR | -107.866% |
| Hikal Limited | 17.84 Billion INR | 6.042% |
| Ind-Swift Limited | 5.02 Billion INR | -233.709% |
| Innova Captab Limited | 10.81 Billion INR | -55.07% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 21.381% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -703.433% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 74.984% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -188.826% |
| Lupin Limited | 196.56 Billion INR | 91.47% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -356.449% |
| Medico Remedies Limited | 1.44 Billion INR | -1057.033% |
| Morepen Laboratories Limited | 17.01 Billion INR | 1.476% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 0.462% |
| Orchid Pharma Limited | 8.19 Billion INR | -104.643% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -45.647% |
| RPG Life Sciences Limited | 5.82 Billion INR | -188.082% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -986.191% |
| Sigachi Industries Limited | 3.98 Billion INR | -320.292% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -35.4% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -59.488% |
| Themis Medicare Limited | 3.81 Billion INR | -339.223% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1.168% |
| Vaishali Pharma Limited | 862.79 Million INR | -1843.424% |
| Wanbury Limited | 5.75 Billion INR | -191.285% |
| Windlas Biotech Limited | 6.3 Billion INR | -165.752% |
| ZIM Laboratories Limited | 3.67 Billion INR | -356.246% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -30.906% |
| Ipca Laboratories Limited | 77.05 Billion INR | 78.24% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 96.542% |
| Venus Remedies Limited | 5.91 Billion INR | -183.503% |
| Sakar Healthcare Limited | 1.54 Billion INR | -987.637% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 94.218% |
| Divi's Laboratories Limited | 78.45 Billion INR | 78.626% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -29.428% |
| Mankind Pharma Limited | 103.34 Billion INR | 83.775% |
| Sequent Scientific Limited | 13.69 Billion INR | -22.417% |
| Laurus Labs Limited | 50.01 Billion INR | 66.476% |
| Neuland Laboratories Limited | 15.58 Billion INR | -7.584% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 51.365% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 85.806% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 91.185% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -298.067% |
| Wockhardt Limited | 27.89 Billion INR | 39.879% |
| Bal Pharma Limited | 3.39 Billion INR | -394.305% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 93.994% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -117.694% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -1653.213% |
| Shilpa Medicare Limited | 11.53 Billion INR | -45.414% |
| Valiant Laboratories Limited | 1.82 Billion INR | -821.018% |
| Ajanta Pharma Limited | 42.08 Billion INR | 60.159% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -323.838% |
| Granules India Limited | 45.06 Billion INR | 62.791% |
| Medicamen Biotech Limited | 1.79 Billion INR | -835.149% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -546.796% |
| Piramal Enterprises Limited | 60.33 Billion INR | 72.21% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 84.189% |
| NATCO Pharma Limited | 40.02 Billion INR | 58.101% |
| Suven Life Sciences Limited | 116.92 Million INR | -14240.155% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -3225.526% |
| Strides Pharma Science Limited | 40.51 Billion INR | 58.61% |
| Indoco Remedies Limited | 18.17 Billion INR | 7.732% |
| Alpa Laboratories Limited | 1.08 Billion INR | -1442.023% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -1507.112% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -2119.569% |